MetLife
MetLife, Inc.
Key figures
Period Jan 2025 to Dec 2025ConsolidatedU.S. GAAP
RevenueDisclosed
US$77.1B
Operating marginCalculated
8.0%
Net assets to total assetsCalculated
3.8%
Company profile
Tables scroll sideways
Disclosed data
Profitability
★★☆☆☆position among all companies
8.0%
Growth (revenue, 4-year average)
★★☆☆☆position among all companies
2.9%
Capital efficiency
★★★☆☆position among all companies
11.9%
Revenue and profit
Performance, financial position and capital allocation
MetLife
Recent performance trends
MetLife
Cash flow trends
Consolidated indicators (9 items)
| Item | 4 years ago | 3 years ago | 2 years ago | Last year | This year |
|---|---|---|---|---|---|
| Net sales | US$68.7 billion | US$68.8 billion | US$66.9 billion | US$71.0 billion | US$77.1 billion |
| Operating income | Could not be retrieved | US$6.0 billion | US$5.7 billion | US$6.0 billion | US$6.1 billion |
| Net income | US$6.9 billion | US$5.3 billion | US$1.6 billion | US$4.4 billion | US$3.4 billion |
| Total assets | US$759.7 billion | US$663.1 billion | US$687.6 billion | US$677.5 billion | US$745.2 billion |
| Shareholders' equity | US$67.5 billion | US$29.9 billion | US$30.0 billion | US$27.4 billion | US$28.4 billion |
| Net cash provided by (used in) operating activities | US$12.3 billion | US$13.0 billion | US$13.7 billion | US$14.6 billion | US$17.1 billion |
| Net cash provided by (used in) investing activities | US$-11.2 billion | US$-2.6 billion | US$-10.2 billion | US$-11.5 billion | US$-15.6 billion |
| Net cash provided by (used in) financing activities | US$-1.1 billion | US$-9.9 billion | US$-2.9 billion | US$-3.1 billion | US$0.2 billion |
| Cash and cash equivalents | US$20.0 billion | US$20.2 billion | US$20.6 billion | US$20.1 billion | US$22.0 billion |
Revenue scale in the same industry
MetLife
Insurance carriers: 54 companies · revenue · largest first・FY Dec 2025・Consolidated・Disclosed
- 1 UnitedHealth Group US$447.6B
- 2 Berkshire Hathaway US$371.4B
- 3 The Cigna Group US$274.9B
- … 2 companies
- 6 Humana US$129.7B
- 7 Progressive CORP/OH/ US$87.7B
- 8 MetLifeThis company US$77.1B
- 9 Allstate US$67.7B
- 10 Prudential Financial US$60.8B
- … 44 companies
Sources and methodology
Basic indicators
| Item | Value | Consolidated / Non-consolidated | Source |
|---|---|---|---|
| Cash and cash equivalents | US$22.0 billion | Consolidated | Disclosed |
| Net cash provided by (used in) financing activities | US$0.2 billion | Consolidated | Disclosed |
| Net cash provided by (used in) investing activities | US$-15.6 billion | Consolidated | Disclosed |
| Net cash provided by (used in) operating activities | US$17.1 billion | Consolidated | Disclosed |
| Depreciation and amortization | US$0.1 billion | Consolidated | Disclosed |
| Dividends paid | US$1.5 billion | Consolidated | Disclosed |
| Stockholders' equity (including non-controlling interests) | US$28.7 billion | Consolidated | Disclosed |
| Non-controlling interests | US$0.3 billion | Consolidated | Disclosed |
| Net assets | US$28.4 billion | Consolidated | Disclosed |
| Net sales | US$77.1 billion | Consolidated | Disclosed |
| Operating income | US$6.1 billion | Consolidated | Disclosed |
| Net income | US$3.4 billion | Consolidated | Disclosed |
| Total assets | US$745.2 billion | Consolidated | Disclosed |
| Purchase of treasury stock | US$2.9 billion | Consolidated | Disclosed |
| Operating margin | 8.0% | Consolidated | Calculated |
| Net assets to total assets | 3.8% | Consolidated | Calculated |
| Net margin | 4.4% | Consolidated | Calculated |
| Return on equity | 11.9% | Consolidated | Calculated |